Cytosorbents Corp
CTSO
54 hedge funds and large institutions have $20.2M invested in Cytosorbents Corp in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 6 closing their positions.
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
2% more funds holding
Funds holding: 53 → 54 (+1)
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
0.49% more ownership
Funds ownership: 34.35% → 34.84% (+0.49%)
30% less capital invested
Capital invested by funds: $28.7M → $20.2M (-$8.48M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$3.07M |
| 2 |
AC
Avenir Corporation
Alexandria,
Virginia
|
+$496K |
| 3 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$460K |
| 4 |
Neuberger Berman Group
New York
|
+$444K |
| 5 |
Morgan Stanley
New York
|
+$173K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$178K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$108K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$57.7K |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
-$52K |
| 5 |
EP
Eudaimonia Partners
Winchester,
Tennessee
|
-$44.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $40 | +$53 | +36 | New |
|
52
BNP Paribas Financial Markets
Paris,
France
| $3 | – | – | – |
|
53
Qube Research & Technologies (QRT)
London,
United Kingdom
| $1 | – | – | – |
|
|
54
Citadel Advisors
Miami,
Florida
| – | -$57.7K | -30,688 | Closed |
|
|
EP
55
Eudaimonia Partners
Winchester,
Tennessee
| – | -$44.2K | -23,500 | Closed |
|
|
HF
56
HRT Financial
New York
| – | -$19K | -10,256 | Closed |
|
|
HWM
57
HighMark Wealth Management
St. Paul,
Minnesota
| – | -$18.8K | -10,000 | Closed |
|
58
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$11.1K | -7,450 | -99% |
|
59
Barclays
London,
United Kingdom
| – | -$10.5K | -5,577 | Closed |
|
|
PPC
60
Park Place Capital
Homewood,
Alabama
| – | -$1.47K | -781 | Closed |
|
CTSO Hedge Fund Activity: Q4 2023 in Review
54 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2023, worth a combined $20.2M — down 30% from $28.7M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CTSO positions and 6 closed out — a net gain of 2 holders — while 15 added to existing stakes and 14 trimmed.
The largest buyer was Granahan Investment Management, adding an estimated $3.07M. The largest seller was Millennium Management, cutting an estimated $178K.
- 54 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2023, up from 53 in Q3 2023.
- Funds reported $20.2M of Cytosorbents Corp stock for Q4 2023, down 30% quarter-over-quarter.
- 8 funds opened new Cytosorbents Corp positions in Q4 2023 and 6 closed out, a net change of +2 holders.
- The largest Cytosorbents Corp buyer in Q4 2023 was Granahan Investment Management, an estimated $3.07M added.
- The largest Cytosorbents Corp seller in Q4 2023 was Millennium Management, an estimated $178K sold.
Based on aggregated 13F filings for Q4 2023.